Title |
Amniotic membrane extract and eye drops: a review of literature and clinical application
|
---|---|
Published in |
Clinical Ophthalmology, June 2018
|
DOI | 10.2147/opth.s165553 |
Pubmed ID | |
Authors |
Michael S Murri, Majid Moshirfar, Orry C Birdsong, Yasmyne C Ronquillo, Yanning Ding, Phillip C Hoopes |
Abstract |
The amniotic membrane (AM) has a long history of use in the treatment of various diseases of the ocular surface. It contains pluripotent cells, highly organized collagen, anti-fibrotic and anti-inflammatory cytokines, immune-modulators, growth factors, and matrix proteins. It is used to promote corneal healing in severely damaged eyes. Recently, AM extract and AM extract eye drops have been successfully used in clinical applications, including dry eye and chemical burns. We provide an overview on the recent progress in the preparation, mechanisms of action, and use of AM extract/AM extract eye drops for corneal and external eye diseases. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Russia | 1 | 25% |
United States | 1 | 25% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 117 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 15 | 13% |
Student > Ph. D. Student | 13 | 11% |
Student > Postgraduate | 12 | 10% |
Student > Master | 9 | 8% |
Student > Bachelor | 8 | 7% |
Other | 18 | 15% |
Unknown | 42 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 32 | 27% |
Biochemistry, Genetics and Molecular Biology | 9 | 8% |
Agricultural and Biological Sciences | 9 | 8% |
Engineering | 8 | 7% |
Neuroscience | 3 | 3% |
Other | 6 | 5% |
Unknown | 50 | 43% |